The cellular proportion of the NEUD-MDL (Trem2-DAM) progressively increased with age, competing with the pro-inflammatory microglial activation, and thereby contributing to the development of AD chronic neuroinflammation. This evidence concerns the gene TREM2 and Alzheimer disease.